(S)-2-((tert-Butoxycarbonyl)amino)-4-(methylsulfonyl)butanoic acid, 95.0%, 25g

3-Oxo-2,3-dihydropyridazine-4-carboxylic acid, 95.0%, 5g

(S)-3-((tert-Butoxycarbonyl)amino)-3-(2-chlorophenyl)propanoic acid, 95.0%, 100mg

4-(Cyclobutyloxy)benzoic acid, 5g

3-(3,4-Dichlorophenyl)pyrrolidine hydrochloride, 95.0%, 250mg

(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methylpentanoic acid, 95.0%, 1g

2-(1H-Pyrrolo[3,2-b]pyridin-3-yl)ethanamine dihydrochloride, 95.0%, 250mg

3-n-Butoxybenzoic acid, 97.0%, 25g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-((tert-butyldimethylsilyl)oxy)pyrrolidine-2-carboxylic acid, 97%, 1g

1-[(4-methylphenyl)sulfonyl]-3-azetidinone, 95.0%, 25g

Headspace vials ROTILABO® with beaded rim ND20 rounded bottom, Clear glass, DIN rolled edge, 10 ml, 100 Piece(s)

1,4-Dithioerythritol (DTE), 25 g

3,4-Dihydroxybenzaldehyde, 99.0%, 5g